Negligence & Personal Injury
Woman Wins $29 Million for Cancer Caused By Asbestos in Johnson & Johnson Talcum Powder
A jury in California recently awarded $29 million to a woman who claimed that Johnson & Johnson brand talcum powder contained asbestos that caused her cancer.
The verdict came down in state superior court in Oakland, California. It’s just one of more than 13,000 active lawsuits that J&J is facing around the country related to its talc-based products.
The plaintiff, Terry Leavitt, used J&J brand products, including their baby powder and “Shower to Shower” talc-based powder through the 1960s and 1970s. She was diagnosed with mesothelioma—a form of cancer caused by asbestos—in 2017.
During the trial, dozens of experts gave testimony both for the plaintiff and in support of J&J. After two days of deliberation, the jury delivered its verdict, in which they determined that J&J’s talc powder products were defective. The jury also concluded that the company negligently failed to warn consumers of the products’ health risks; however, the jury decided not to award punitive damages against the company. Instead, they found that J&J is liable for $29.4 million in compensatory damages to Ms. Leavitt and her husband.
Counsel for Ms. Leavitt say that the verdict—and the documentary evidence—show that J&J knew about the risk of asbestos in their talc-based products, but that the company worked over decades to cover up the truth, conceal the health risks and deceive the public and consumers.
In December of 2018, the news outlet Reuters published an investigation that showed J&J was aware that the talc in its powder products had tested positive for asbestos. These positive asbestos test results were found starting in the 1970s and through until the early 2000s. In its story, Reuters reported that J&J did not disclose these findings to regulators or to consumers.
Imerys Talc America, the manufacturer of the talc powder that supplied J&J’s products, has filed for bankruptcy from the weight of these talc-based lawsuits. They were initially named as a co-defendant in Ms. Leavitt’s trial; however, they were dropped from the lawsuit by the presiding judge in light of their bankruptcy protection.
In response to the jury’s verdict, J&J denies that their talc-based products contain asbestos and cause cancer. In support of its claim, the company cites scientific studies that show that its baby powder and other talc products are asbestos-free, as well as determinations by governmental regulators clearing the safety of these products.
J&J said that it plans to appeal the decision. The company cited what it calls “serious” evidentiary and procedural errors in the case and in during the trial. J&J further maintains that the plaintiff failed to prove that their baby powder product contains cancer-causing asbestos.
Ms. Leavitt’s case is the first of dozens of lawsuits against J&J for their talc-based products that are scheduled to go to trial this year. To date, there have been 11 total cases alleging asbestos contamination in J&J talc products; only three have resulted in verdicts in favor of the plaintiffs. One case awarded more than $4.6 billion in damages in a multi-plaintiff case alleging that J&J’s talc products caused ovarian cancer.
The company has appealed all of the cases that awarded verdicts in favor of the plaintiff, and it maintains that its products are safe and pose no health or safety risks.
Sunbeam Crockpots Recalled for Burn Injuries
Sunbeam Products has issued a recall of one of its crock pot products due to a burn hazard. The recall came just two days before the Thanksgiving holiday, during a time when crock pots are often in use.
Details of the Crock Pot Recall
The product involved in the recall is the Crock-Pot 6-Quart Express Multi-Cooker. Almost one million of these defective products have been sold. According to the recall, the multi-cooker may pressurize if the lid hasn’t been locked in place completely. The pressure can make the lid to detach when the crock pot is in use. If the hot food or liquid ejects from the pot, it can lead to serious burns.
The recall impacts mostly purchases in the US with almost 29,000 in Canada. The cookers were bought at Walmart, Target and online at Amazon as well as other national retailers. The timeline was from July 2017 and up to the time of the recall. The crock put costs between $70 and $100. To find out if your crock pot is part of the recall, you can look at the bottom of the base or on the electrical plug on one of the prongs for the codes K196JN through K365JN and L001JN through L273JN.
It’s advised that anyone with this product not use it as a pressure cooker, but it can be used for sauted and slow cooking recipes. The company will send lids to consumers for free to replace the defective ones if they contact the manufacturer.
The recall notice advised that if consumers use the product as a pressure cooker, they should make sure the lid is in the fully locked position. They can tell if it is secured by making sure the arrow on the lid is aligned with the lock on the base.
Burn Injuries and the Serious Consequences
Sunbeam has gotten more than 100 reports where the lid detached in use. This resulted in almost 100 burn injuries. These burns range from first-degree to third-degree.
A first-degree burn is considered superficial because it only impacts the first layer of skin. This type of injury may not require medical care, but it can be quite painful. However, some cases may require a visit to the doctor or hospital if it covers a large area or hurts too much. Third-degree burns are much more serious and require immediate medical care because the burn impacts the other layers of skin. Infection is often a major concern with third-degree burns as well as other complications.
A person with a third-degree burn may feel a great deal of pain, but it can also be numb. There is often scarring from this type of burn. However, any burn can be considered serious if not taken care of properly.
While many products are recalled and often ignored, this recall from Sunbeam is considered serious and should not be taken lightly. Anyone with one of these products is at risk for serious and permanent injury.
Negligence & Personal Injury
Traumatic Brain Injury May Increase Risk of Alzheimer’s Disease
According to a new study, people who have had a history of traumatic brain injury, otherwise known as TBI, have an increased risk for developing some type of dementia, including Alzheimer’s disease. The research indicates it may accelerate the onset of the disease by about four years.
TBI and Dementia
Dementia is a general term that may include multiple diseases. All have one thing in common – they include a decline in mental ability. This decline is serious enough that it interferes with their ability to act and interact in daily life as it progresses. One of the most well-known conditions under the term dementia is Alzheimer’s disease.
The causes of dementia can vary but all are triggered by abnormal changes in the brain. They result in a loss of cognitive skills or the ability to think. The loss also impacts the person’s feelings, behaviors and even their relationships with others.
A TBI is caused by a sudden impact to the head. It can happen from a fall or car accident as well as other situations where the person hits their head. A person who experiences a TBI may lose consciousness even for only a few seconds. They may suffer from other symptoms:
- Trouble speaking clearly
- Unable to recall the event that caused the TBI
- Difficulty learning or remembering new information
- Lack of coordination
- Difficulty seeing clearly
- Trouble hearing or ringing in the ears
- Unsteady when walking or standing
A TBI can cause issues even years later when the person seems to have recovered from the injury. A doctor will label a TBI as mild, moderate or severe based on various factors, including how long they were unconscious and severity of other symptoms. However, it is important to understand that even a mild TBI can have serious effects that are long-lasting.
Mild to Severe TBIs
A mild TBI is known as a concussion and it doesn’t result in unconsciousness at all or for more than 30 minutes. The person may experience dizziness or a headache, nausea and confusion, but the symptoms go away in a few hours or days. However, in some cases, they can last for several months.
A moderate TBI causes unconsciousness that lasts between 30 minutes and 24 hours with a severe TBI being over 24 hours of unconsciousness. They have the same symptoms as the mild version, only stronger and may last longer.
The ability to learn new information or remember things and to pay attention are symptoms that can be long-lasting or permanent from a TBI. The person may have difficulty organizing their thoughts or being able to create a plan.
Research in the past had linked moderate to severe TBIs with dementia. New research shows that even a mild TBI or repeated mild TBIs may result in an increased risk for developing some type of dementia. Research shows that a protein seen in Alzheimer’s patients is evident within hours of a mild TBI event. Not everyone who has a TBI will develop dementia, but it is important to be aware of the risk.
Bayer Settles 90% of U.S. Essure Claims for 1.6 Billion
About 90 percent of the more than 39,000 lawsuits filed against Bayer over Essure injuries have been resolved by a $1.6 billion settlement. Bayer said in a statement that the settlement resolves most filed and unfiled cases and that it continues to work with plaintiff’s lawyers to resolve the remaining cases.
FDA Actions and Essure Injury Complaints
The settlement comes after years of complains of adverse events involving the metal coils which are placed in the fallopian tubes. Some of these complaints say that the coils can perforate the tubes, tear the uterus, and that the coils can break causing little metal shards to migrate elsewhere in the body. Women have also complained of heavy bleeding, pain, and other side effects that the patients were forced to undergo hysterectomy.
In 2018, the U.S. Food and Drug Administration placed restrictions on the device and required patients to review the Patient- Doctor Discussion Checklist and sign prior to being implanted with the birth control device. Bayer made the decision to stop selling Essure in the United States not long after citing declining sales.
Post-Market Surveillance Reports
The required 522 study, a post-marketing surveillance plan, was also extended by the FDA from three to five years. The FDA published the first spreadsheet of Essure adverse events on August 11, 2020, which includes events that Bayer knew or learns of during the period of November 2016 to November 2020.
The first spreadsheet includes more than 1,400 events including pain, device fragments, pregnancy, and organ perforations, including 1376 reports of serious injury, 53 reports of death and 24 reports of malfunction.
Essure Lawsuit Settlement
Many of the plaintiffs alleged in court filings that Bayer knew or should have known about the risk of adverse events, including organ perforation, device breakage, and device migration. They also allege that Essure birth control was improperly design and can break and migrate after being implanted. They accused Bayer of misrepresenting the efficacy and safety of the contraceptive device and Women who suffered Essure injuries alleged in court filings that Bayer concealed the risks and dangers of the device from the FDA, the medical community and from the women who relied on the device.
Many of the terms of the settlement are confidential, and Bayer did not admit to any wrongdoing in the court filings.
Defective Products3 years ago
Dehumidifier Recall: Several Brand Name Humidifiers are Recalled as a Fire Hazard
Medical Devices4 years ago
Complications from Hernia Mesh
Covid-193 years ago
Metformin as Potential Protector from COVID-19
Covid-192 years ago
Moderna Seeks Emergency Approval for COVID Vaccine
Prescription Drugs2 years ago
Recall for Drug Mix-up with Serious Effects
Prescription Drugs3 years ago
Some Heart Meds May Come with Extra Risk
Covid-193 years ago
FDA Adds Nearly Two Dozen Drugs to Watch List
Prescription Drugs2 years ago
Senate Bill May Give More Authority to the FDA for Drug Recall